BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Engineered adult stem cells: A promising tool for anti-cancer therapy
Youngdong Choi 1 (Graduate student), Kyung-Chul Choi 1,* (Professor), Hong Kyu Lee 1 (post-doctoral Fellow), Hong Kyu Lee 1 (Postdoctoral fellow), Kyung-Chul Choi 1 (Professor)
1Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University
Cancers are one of the most dreaded diseases in human history and have been targeted by numerous trials including surgery, chemotherapy, radiation therapy, and anti-cancer drugs. Adult stem cells (ASCs), which can regenerate tissues and repair damage, have emerged as leading therapeutic candidates due to their homing ability toward tumor foci. Stem cells can precisely target malicious tumors, thereby minimizing the toxicity of normal cells and unfavorable side effects. ASCs, such as mesenchymal stem cells (MSCs), neural stem cells (NSCs), and hematopoietic stem cells (HSCs), are powerful tools for delivering therapeutic agents to various primary and metastatic cancers. Engineered ASCs act as a bridge between the tumor sites and tumoricidal reagents, producing therapeutic substances such as exosomes, viruses, and anti-cancer proteins encoded by several suicide genes. This review focuses on various anti-cancer therapies implemented via ASCs and summarizes the recent treatment progress and shortcomings.
Abstract, Accepted Manuscript(in press) [Submitted on May 28, 2022, Accepted on November 4, 2022]
  © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd